Expanding the applications of immune checkpoint inhibitors in advanced lung cancer beyond disease progression

Expanding the applications of immune checkpoint inhibitors in advanced lung cancer beyond disease progression

BackgroundImmunotherapy, particularly the utilization of immune checkpoint inhibitors (ICIs), assumes a pivotal role in the comprehensive management of advanced lung cancer. There has been substantial deliberation regarding the appropriateness of extending ICIs treatment beyond the point of disease...

Full description

Bibliographic Details
Main Authors: Chao Chen, Xi Xiong, Ying Cheng, Haiyun Gen, Wenqiang Zhu, Fei Zhang, Chuandong Zhu, Siqi Han, Xiufeng Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
advanced lung cancer
PD-1
treatment beyond progression
immunotherapy
retrospective study
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1266992/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1266992/full

Similar Items